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Inhalation Toxicology of Isoprene in F344
Rats and B6C3F1 Mice Following Two-
Week Exposures
by Ronald L. Melnick,* Joseph H. Roycroft,* Billy J.
Chou,t Harvey A. Ragan, and Rodney A. Millert
Isoprene (2-methyl-1,3-butadiene) was selected for toxicologic evaluations because of its structural
similarity to 1,3-butadiene, apotent rodent carcinogen. Two-week inhalation toxicology studies ofisoprene
were conducted in F344 rats and B6C3F1 mice at exposure concentrations of0, 438, 875, 1750, 3500, or 7000
ppm. For rats, there were no chemically related changes in survival, body weight gain, clinical signs,
hematologic orclinical chemistryparameters, orgrossormicroscopic lesions. Exposure ofmice to isoprene
did not produce mortalities and only caused a decrease in body weight gain for male mice in the 7000 ppm
exposure group; however, hematologic changes and microscopic lesions including testicular atrophy,
olfactoryepithelialdegeneration, andforestomachepithelial hyperplasiawereobservedin isoprene-exposed
mice. Similar toxicologic effects have been previously observed in B6C3F1 mice exposed to 1,3-butadiene. A
speciesdifference insusceptibility between rats andmiceexposedtoisoprenewasevidentintheseshort-term
exposure studies.
Introduction
Isoprene (2-methyl-1,3-butadiene; CAS No. 78-79-5)
was selected for toxicologic evaluations because of its
structural similarity to 1,3-butadiene. The latter com-
pound produced one ofthe most unusual responses in a
long-term study by the National Toxicology Program
(1,2): ahigh rate ofearlymortality due to fatal tumors in
B6C3F1 mice exposed to 625 or 1250 ppm of 1,3-bu-
tadiene, seven primary sites ofneoplastic development,
and induction of uncommon tumors such as hemangio-
sarcoma ofthe heart. To investigate the influence ofthe
2-methyl substituent on the toxicologic profile of 1,3-
butadiene, inhalation toxicology studies of isoprene
were initiated.
Isoprene differs physically from butadiene in that it is
a liquid at room temperature (boiling point: 34°C),
whereas butadiene is a gas (boiling point: -4.4C).
Isoprene is a high volatile material, having a vapor
pressure of493 mm Hg at 200C (3). The annual produc-
tionvolume ofisoprene inthe United States is about 140
million pounds; this levelis about 6% ofthe U.S. produc-
tion volume of 1,3-butadiene (4). Isoprene is produced
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principally for the synthesis of cis-1,4-polyisoprene (5),
which is used in the manufacture ofrubber tires, auto-
motive parts, gaskets, footwear, adhesives, and
flooring.
Few toxicology studies have been published on iso-
prene. The LC50 value for isoprene was reported to be
about 50,000 ppm in mice after 2 hr of exposure, and
64,500 ppm in rats after 4 hr ofexposure (6). Inhalation
exposure of B6C3F1 mice to 438, 1750, or 7,000 ppm
isoprene, 6 hr/day, 5 days/week for 2 weeks, induced
increases inthefrequency ofsisterchromatidexchanges
in bone marrow cells and in the levels ofmicronucleated
erythrocytes in peripheral blood at all exposure levels
(7). Isoprene is metabolized to the monoepoxides
3,4-epoxy-3-methyl-1-butene and 3,4-epoxy-2-methyl-
1-butene and to isoprene diepoxide (2-methyl-
1,2,3,4-diepoxybutane) by liver microsomal monooxy-
genases ofmice, rats, rabbits, and hamsters (8,9). Iso-
prenediepoxide wasmutagenic toSalmonellatyphimu-
rium strains TA98 and TA100 (10). The maximal rate of
metabolism of isoprene in B6C3F1 mice is about three
times greaterthanthatinWistarrats (11). Isoprene has
been identified as themajor endogenoushydrocarbon of
humanbreath(12,13), exhaled atarateofapproximately
28 nmole/L. Isoprene is produced endogenously by rats
and mice at rates of 1.9 and 0.4 ,umole/hr/kg, respec-
tively (11). 'This paper gives results of the effects of
inhalation exposure of F344 rats and B6C3F1 mice to
isoprene vapors.MELNICK ET AL.
Materials and Methods
Chemical and Exposure System
Isoprene, containing about 50 ppm of the peroxide
inhibitor t-butyl catechol, was obtained from the Good-
year Tire and Rubber Company. The lots of isoprene
used in these studies had purities greater than 99%; the
largest impurity identified (approximately 0.2%) was
limonene, a dimer of isoprene. Isoprene vapors were
generated in a Buchi Rotavapor system at 65°C, carried
in nitrogen through a chilled water condenser to a dis-
tribution manifold, and then separately metered to each
exposure chamber. Chamber concentrations ofisoprene
were regulated by adjusting the metering valves which
controlled individual delivery lines fromthe distribution
manifold and by adjusting the pressure of the com-
pressed air in which the isoprene vapors were diluted
prior to entry into the exposure chambers. Con-
centrations ofisoprene in the chambers were measured
continuously during the exposures with a Hewlett-
Packard 5840 gas chromatograph equipped with a flame
ionization detector (oven temperature: 120°C; GC
column: 12" x 1/8" nickel column packed with 1%
SP-1000 on 60/80 Carbopack B; carrier gas: nitrogen).
The daily mean concentrations ofisoprene for all cham-
bers were within 2% of the target concentrations.
Animal Maintenance
Four-week-old F344 rats and B6C3F1 mice ofeach sex
were purchased from Simonsen Laboratories (Gilroy,
CA) and quarantined for 10 to 13 days prior to the start
of the study. Stainless steel Hazelton 2000 chambers
(total volume 2.3 m3) were used, and animals were
exposed in individual wire mesh cage units. The floor
area ofthe mouse cage is 106 cm2 and the rat cage is 270
cm . Chamber environment was maintained at 75 3°F
and55 + 15%relativehumidity, withchamberairflowat
15 changes/hr. Fresh softened tap water and NIH-07
diet were available ad libitum, except during the ex-
posure periods when the feed was removed.
Treatment Groups
Groups of20 rats of each sex and 20 mice of each sex
were exposed to chamber atmospheres of 0 (control),
438, 875, 1750, 3500, or7000 ppmisoprene for6hr + T90
per day, 5 days per week for 2 weeks. The time interval
required to reach 90% ofthe target concentration, T90,
wasabout 12min. Animals were observedtwicedailyfor
moribundity and mortality. Bodyweight measurements
and clinical observations were made weekly. Ten ani-
mals per group were used for clinical pathology evalua-
tionsafter4to5 exposures; theremaining 10animals per
group were used for histopathology at the end of the
study. The exposure schedule ensured that there were
at least 2 consecutive exposure days prior to terminal
sacrifice; within 24 hr ofthe last exposure, all surviving





included hematology (erythrocyte, leukocyte, and plate-
let counts, leukocyte differential counts, hemoglobin
concentration, volume ofpacked red cells, mean corpus-
cular volume, mean corpuscular hemoglobin, mean cor-
puscular hemoglobin concentration and reticulocyte
count), serum clinical chemistry (urea nitrogen, creati-
nine, sorbitol dehydrogenase, glutamic pyruvic trans-
aminase, and glutamate dehydrogenase), and urinalysis
(rats only) of 16-hr urine samples collected over ice
(volume, pH, appearance, specific gravity, protein, glu-
cose, urea, creatinine, alkaline phosphatase, and glu-
tamic oxaloacetic transaminase). Blood samples were
collected from the supraorbital sinus of CO2-
anesthetized animals intotubeseithercontainingEDTA
or free of EDTA. Hematologic indices were measured
with an Ortho ELT-8/ds hematology analyzer, while
serum and urine chemistries were performed with an
Abbott VP chemistry analyzerusingAbbott VP metho-
dologies. Urine protein concentration was determined
by the Coomassie blue reaction (14).
Histopathology
Tissue samples that were preserved in 10% neutral
buffered formalin were trimmed, embedded in paraffin,
sectioned, and stained with hematoxylin and eosin. The
following tissues were examined microscopically from
control and high-dose groups: gross lesions, liver, lungs
and mainstem bronchi, nasal cavity and turbinates,
trachea, larynx, tracheobronchial lymph nodes, heart,
brain, thymus, spleen, kidneys, and testes/epididymis.
Target organs and gross lesions were examinedin lower
dose groups until an apparent no-observed-effect level
was found.
Statistics
Mean body weights, organ weights, organ weight/
body weight ratios, and clinical pathology results of
treatedgroupswerecompared tothoseofcontrolgroups
using the Dunnett's t-test. The minimum level ofproba-
bility accepted for significance was p < 0.05.
Results
Therewere nodeathsofF344ratsexposedtoisoprene
vapors for 2 weeks at exposure concentrations ranging
from 438 to 7000 ppm. Slight differences in final mean
body weight or mean bodyweight gain were not signifi-
cant at any of the exposure levels when compared to
those of control rats (Table 1). There were also no
significant differences in mean organ weights (thymus,
kidney, heart, lung, spleen, brain, liver, or testis) or
organ weight/body weight ratios of rats exposed to
isoprene compared to those of controls. In addition,
there were no clinical pathology changes or gross or
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Table 1. Final mean body weight and body weight gain for F344 rats exposed to isoprene by inhalation for 2 weeks.
Malesa Femalesb
Exposure concentration, Finalbodyweight, Meanbodyweightgain, Finalbodyweight, Meanbodyweightgain,
ppm g g g g
0 160 ± 12 76.7 ± 6.3 121 ± 8 43.2 ± 2.9
438 158± 15 73.6 ± 8.5 117 ± 10 38.6 ± 10.0
875 152 ± 18 70.5 ± 11.6 122 ± 6 44.2 ± 2.1
1750 152 ± 15 70.5 ± 9.8 119 ± 8 42.3 ± 3.5
3500 151 ± 11 71.6 ± 7.5 119 ± 5 45.8 ± 1.9
7000 150 ± 17 68.2 ± 8.8 119 ± 6 43.3 ± 3.6
aInitial mean body weight ofmale rat groups was 82.1 ± 1.9 g.
bInitial mean body weight offemale rat groups was 76.6 ± 2.1 g.
Table 2. Final mean body weight and body weight gain for B6C3Fj mice exposed to isoprene by inhalation for 2 weeks.
Malesa Femalesb
Exposure concentration, Finalbodyweight, Meanbodyweightgain, Finalbodyweight, Meanbodyweightgain,
ppm g g g g
0 28.7 ± 1.8 5.0 ± 1.9 22.6 ± 0.9 2.1 ± 0.6
438 27.1 ± 1.2* 3.9 ± 1.1 22.6 ± 0.9 2.8 ± 1.1
875 26.4 ± 1.2* 3.7 ± 0.6 23.0 ± 0.6 3.4 ± 0.8*
1750 27.2 ± 1.2* 4.2 ± 0.9 22.5 ± 1.1 2.7 ± 0.8
3500 26.7 ± 1.2* 4.0 ± 0.8 22.9 ± 0.8 3.4 ± 0.6*
7000 24.3 ± 1.2* 1.7 ± 0.9* 22.3 ± 1.0 2.5 ± 0.7
aInitial mean body weight ofmale mouse groups was 23.0 ± 0.4 g.
bInitial mean body weight offemale mouse groups was 19.9 ± 0.4 g.
*Different from control (0 ppm), p < 0.05.
Table 3. Mean organ weight/body weight ratios (x 1000) for male B6C3F1 mice exposed to isoprene by inhalation for 2 weeks.
Exposure concentration,
ppm Liver Thymus Spleen Right testis
0 50.3 0.21 1.62 ± 0.024 2.7 ± 0.3 3.61 ± 0.33
438 56.0±2.0* 1.43±0.18 2.5±0.2 3.49 ±0.25
875 59.4 2.8* 0.99 ± 0.25* 2.3 ± 0.2* 3.15 ± 0.17*
1750 59.7 2.0* 1.10 ± 0.29* 2.3 ± 0.2* 3.08 ± 0.23*
3500 62.3 4.4* 0.90±0.12* 2.3 ±0.1* 3.10±0.15*
7000 67.3 3.1* 0.60 ± 0.19* 2.0 ± 0.1* 2.84 + 0.16*
*Different from control (0 ppm), p < 0.05.
histopathological lesions that could be attributed to ex-
posure to isoprene.
There were no deaths of B6C3F1 mice exposed to
isoprene for 2 weeks. A 15% reduction in body weight
was observed inthe 7000 ppm group ofmale mice (Table
2). Exposuretoisoprene did not cause reductionin mean
bodyweightgain offemale mice. Dose-related increases
in meanliverweight/bodyweightratios anddecreases in
relative thymus, spleen, and testis weights were ob-
served in mice exposed to isoprene compared to con-
trols. Organweightchanges were observed inboth male
and female mice; results for males are shown in Table 3.
In blood samples of mice exposed for 5 consecutive
daystoisoprene, meanredblood cellcounts, hemoglobin
concentrations, and volume of packed red cells were
reduced in all exposure groups when compared to con-
trols (Table 4). These changes were not dose related nor
accompanied by increases inreticulocyte counts orpoly-
chromatic erythrocytes. Similar hematologic changes
were observed in male and female mice. The lack of
exposure-related changes in serum chemistry parame-
ters in mice indicates that the hepatic and renal systems
Table 4. Hematologic changes in peripheral blood ofB6C3F1 mice
exposed to isoprene by inhalation for 5 days.a
Exposure concentration, RBC HGB, VPRC,
ppm x 106/RL g/dL mL/dL
Males
0 9.90±0.35 16.4±0.5 48.9 1.9
438 9.11 ± 0.32* 15.1 ± 0.4* 44.9 1.2*
875 9.19±0.25* 15.2±0.3* 45.2±1.1*
1750 8.76 ± 1.01* 14.6 ± 1.7* 43.2 4.8*
3500 9.01 ± 0.13* 15.0 ± 0.2* 44.6 0.5*
7000 9.18 ± 0.20* 15.0 ± 0.2* 44.7± 1.2*
Females
0 9.74±0.20 16.4±0.2 48.1±0.7
438 9.20±0.30* 15.6 ±0.4* 45.6±0.8*
875 9.03 ± 0.19* 15.4 ± 0.3* 45.5 ± 0.8*
1750 9.20±0.30* 15.5±0.3* 45.3 ±0.8*
3500 9.24 ± 0.32* 15.7 ± 0.5* 45.9 ± 1.5*
7000 9.06 ± 0.35* 15.4 ± 0.4* 45.2 ± 1.3*
aAbbreviations: RBC; red blood cell count; HGB; hemoglobin con-
centration; VPRC; volume of packed red cells.




Inhalation exposure of male mice to isoprene for 2
weeks was associated with microscopic changes in the
thymus, testes, nasal cavity, and forestomach; micro-
scopic lesions in the forestomach were also observed in
exposed female mice (Table 5). Thymic atrophy in male
miceexposedto7000ppmisoprenewascharacterizedby
adecreaseincellularityofthe cortex. Minimaltesticular
atrophy was observed in mice exposed to 7000 ppm
isoprene. Thislesion wasscattered andcharacterizedby
aminimallossofthegerminalepitheliumandareduction
in the number of viable cells along some of the semin-
iferous tubule basement membranes. Diffuse liver
changes consistent with highly glycogenated hepato-
cyteswereobservedtosimilardegreesinalldosegroups
ofexposed male mice. Olfactory epithelial degeneration
was observed at 1750, 3500, and 7000 ppm isoprene; the
severity of the nasal lesions increased with increasing
concentrations ofisoprene. Olfactorydegeneration(Fig.
1) was characterized by focal loss of sensory epithelial
cells and thinning ofthe olfactory epithelium along the
dorsalmeatusofthemiddleandposteriornasalsections.
Atrophy of sensory nerve bundles and submucosal fi-
brosis were observed in some animals in the 7000-ppm
exposure group.
Epithelial hyperplasia ofthe forestomach was seen in
all groups ofmale and female mice exposed to isoprene.
Grossly, theselesionsappeared asfocal, white, raised or
thickened areas at the anteriorpole ofthe forestomach.
Microscopically (Fig. 2), these lesions were character-
ized by focal epithelial cell proliferation resulting in a
thickened and occasionally verrucous appearance. Hy-
perkeratosis and thickening of the muscle layer below
the epithelial lesion were also apparent. The severity of
thelesionwasrelativelyconsistentthroughouttheexpo-
Table 5. Incidence of microscopic lesions in B6C3F1 mice exposed to isoprene by inhalation for 2 weeks.
Exposure concentration, ppm
Target: lesion 0 438 875 1750 3500 7000
Males
Thymus: atrophy o/loa NEb NE NE 0/10 7/9
Testes: atrophy 0/10 NE NE NE 0/10 9/10
Liver: vacuolized cytoplasm 0/10 8/10 9/10 10/10 10/10 10/10
Nose: olfactory epithelial degeneration 0/10 NE 0/10 3/10 6/10 9/10
Forestomach: epithelial hyperplasia 0/10 3/10 5/10 10/10 8/10 9/10
Females
Forestomach: epithelial hyperplasia 0/10 8/10 7/10 10/10 9/10 9/10
aIndicates number ofanimals with lesions/number of animals examined.
bNE, not examined microscopically.r..........:.:.......




FIGURE 1. Nasal olfactory epithelial sections from a control male mouse (A) and a 7000-ppm male mouse (B). Note the loss ofsensory epithelial
thinning of the olfactory epithelium, atrophy of sensory nerve bundles, and submucosal fibrosis in the mouse exposed to isoprene. x50.
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FIGURE 2. Forestomach ofa controlfemale mouse (A) and a 7000 ppm female mouse (B). Epithelial hyperplasia and hyperkeratosis were
observed in mice exposed to isoprene. x 50.
sure groups; a no apparent observable-effect level for
this lesion was not achieved at the exposure concentra-
tions used in this study.
Discussion
Inhalation exposure of F344 rats to isoprene for 2
weeks at concentrations up to 7000 ppm (nearly 50% of
the flammable level of this compound) did not affect
hematologic and clinical chemistry parameters, body
weight gain, or survival, orproduce any apparent gross
ormicroscopic lesions. Exposure ofB6C3F1 mice to the
same atmospheric concentrations of isoprene did not
produce mortality and caused a decrease inbodyweight
gain only in males in the 7000-ppm exposure group. The
following treatment-related effects were observed in
isoprene-exposed mice: a) slight increases in liver
weight; b) decreases in thymus, spleen, and testis
weights; c) hematologic changes(reductions inredblood
cell counts, hemoglobin concentrations, and volume of
packed red cells); and d) microscopic lesions including
thymus and testicular atrophy, olfactory epithelial de-
generation, and forestomach epithelial hyperplasia.
Many of the effects of exposure to isoprene have been
observed in B6C3F1 mice exposed to 1,3-butadiene
(1,2,15,16). The changes in spleen weights in mice ex-
posed to isoprene were not associated with histopatho-
logical alterations in this organ. The significance ofthe
observedchangesintheliverofmalemicebutnotfemale
mice, is unclear.
Mean corpuscular volume was increased in B6C3F1
mice exposed to 625 or 1250 ppm 1,3-butadiene for 6
weeks orlonger(15,16); thischange was notobserved in
miceexposed toisoprene for5days atconcentrations up
to 7000 ppm. Whether the absence ofthis effect was due
to the short exposure period of5 days will be evaluated
in ongoing inhalation studies of isoprene with 13-week
and 6-month exposures.
Testicular atrophy and epithelial hyperplasia of the
forestomach were prominent effects of inhalation ex-
posure of B6C3F1 mice to 1,3-butadiene (1,2,15,16).
Butadiene-induced hyperplasia ofthe forestomach may
represent an early change in the development of fore-
stomach neoplasms that were increased in incidence in
B6C3F1 mice exposed to 625 or 1250 ppm 1,3-butadiene
(1,2,16). Chronicolfactorylesions werepredominantly a
male effect in mice exposed to 1,3-butadiene (1,2).
The lack ofany observable toxicologic effects in F344
rats exposed to isoprene for 2 weeks provides pre-
liminary evidence for a species difference between rats
and mice in susceptibility to isoprene. Gage (17) also did
notobserveanytoxicsignsorhistopathologicchangesin
rats exposed 6 hr/day for 15 days to 1670 ppm isoprene;
thelungsofratsexposedfor6daysto6000ppmisoprene
were slightly congested.
A structure/activity relationship between isoprene
andtherodentcarcinogen1,3-butadieneisevident. Both
compounds induce increases in the frequency of sister
chromatid exchanges in bone marrow cells and in the
levels of micronucleated erythrocytes in peripheral
blood ofmice (7,18); bothcompounds canbemetabolized
to monoepoxide and diepoxide intermediates by liver
microsomal monooxygenases (8,9,19,20), the diepoxide
intermediates ofboth compounds are mutagenic in Sal-
monella(10,21); bothcompounds causereductions inred
blood cell counts, hemoglobin concentrations, and vol-
ume of packed red cells in mice; and both compounds
produced olfactory epithelial changes, testicular atro-
phy, andforestomachepithelialhyperplasiainmice. Due
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exposure studies of isoprene at concentrations ranging
from70to7000ppmhavebeeninitiated inF344ratsand
B6C3F1 micetodeterminewhetherisopreneactssimilar
to 1,3-butadiene after longer exposure durations.
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